BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27678272)

  • 21. Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
    Nonomura N; Oka D; Nishimura K; Nakayama M; Inoue H; Mizutani Y; Miki T; Okuyama A
    Int J Urol; 2007 Jun; 14(6):527-31. PubMed ID: 17593098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paclitaxel, ifosfamide and cisplatin (TIP) beyond its original indication for salvage treatment of germ cell tumors.
    Voss MH; Feldman DR
    Onkologie; 2011; 34(8-9):410-1. PubMed ID: 21934338
    [No Abstract]   [Full Text] [Related]  

  • 23. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.
    Motzer RJ; Sheinfeld J; Mazumdar M; Bains M; Mariani T; Bacik J; Bajorin D; Bosl GJ
    J Clin Oncol; 2000 Jun; 18(12):2413-8. PubMed ID: 10856101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage high-dose chemotherapy for germ cell tumors.
    Feldman DR; Powles T
    Urol Oncol; 2015 Aug; 33(8):355-62. PubMed ID: 25837842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.
    Harstrick A; Schmoll HJ; Wilke H; Köhne-Wömpner CH; Stahl M; Schöber C; Casper J; Bruderek L; Schmoll E; Bokemeyer C
    J Clin Oncol; 1991 Sep; 9(9):1549-55. PubMed ID: 1651992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel in salvage therapy for germ cell tumors.
    Motzer RJ
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-83-S15-85. PubMed ID: 9346229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germ-cell tumors.
    Kondagunta V; Galsky MD; Sonpavde G
    N Engl J Med; 2007 Oct; 357(17):1773; author reply 1773-4. PubMed ID: 17969229
    [No Abstract]   [Full Text] [Related]  

  • 30. Ifosfamide in testicular cancer.
    Loehrer PJ
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):2-5. PubMed ID: 2159186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage Therapy for Patients With Germ Cell Tumor.
    Rashdan S; Einhorn LH
    J Oncol Pract; 2016 May; 12(5):437-43. PubMed ID: 27170693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
    Kondagunta GV; Bacik J; Donadio A; Bajorin D; Marion S; Sheinfeld J; Bosl GJ; Motzer RJ
    J Clin Oncol; 2005 Sep; 23(27):6549-55. PubMed ID: 16170162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
    Marwaha S; Venner PM; North SA
    Can J Urol; 2007 Oct; 14(5):3692-6. PubMed ID: 17949524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.
    Motzer RJ; Bajorin DF; Vlamis V; Weisen S; Bosl GJ
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):8-11. PubMed ID: 1336624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High dose chemotherapy in germ cell tumors.
    Rosti G; De Giorgi U
    Tunis Med; 2005 Dec; 83 Suppl 12():85-6. PubMed ID: 16430076
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of Refractory Germ Cell Cancer.
    Lorch A
    Am Soc Clin Oncol Educ Book; 2018 May; 38():324-329. PubMed ID: 30231348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [High dose chemotherapy and germ cell tumor].
    Massard C; Fléchon A; Fizazi K; Droz JP
    Bull Cancer; 2011 Aug; 98(8):945-9. PubMed ID: 21821481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
    Bokemeyer C
    Oncology; 1998; 55(3):177-88. PubMed ID: 9560052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemotherapy-resistant germ cell cancer of the testis treated by salvage surgery: a case report].
    Taue R; Harada A; Katto K; Yamamoto Y; Kishimoto T; Nakatuji Y; Tanimoto S; Oka N; Izaki H; Fukumori T; Takahashi M; Nishitani M; Kanayama HO
    Hinyokika Kiyo; 2006 Apr; 52(4):293-6. PubMed ID: 16686359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.
    Rick O; Bokemeyer C; Beyer J; Hartmann JT; Schwella N; Kingreen D; Neureither S; Metzner B; Casper J; Wandt H; Hartmann F; Schmoll HJ; Derigs G; Gerl A; Berdel WE; Kanz L; Siegert W
    J Clin Oncol; 2001 Jan; 19(1):81-8. PubMed ID: 11134198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.